Drug Shortage Report for SANDOZ RIVASTIGMINE

Last updated on 2021-11-29 History
Report ID 149283
Drug Identification Number 02324571
Brand name SANDOZ RIVASTIGMINE
Common or Proper name RIVASTIGMINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) RIVASTIGMINE
Strength(s) 3MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100HGC BO
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-15
Estimated end date 2021-12-17
Actual end date
Shortage status Actual shortage
Updated date 2021-11-29
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-11-15 English Compare
v2 2021-11-15 English Compare
v3 2021-11-15 French Compare
v4 2021-11-16 English Compare
v5 2021-11-24 English Compare
v6 2021-11-24 French Compare
v7 2021-11-29 English Compare
v8 2021-11-29 French Compare